imiquimod has been researched along with Vascular Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Duarte, J; Gómez-Guzmán, M; Jiménez, R; O'valle, F; Robles-Vera, I; Romero, M; Sánchez, M; Toral, M; Visitación, N | 1 |
Brand, A; Clausen, BE; Daiber, A; Karbach, S; Klebow, S; Kolbinger, F; Kossmann, S; Münzel, T; Roohani, S; Schüler, R; Ullmann, E; Veras, FP; Waisman, A; Wenzel, P; Wild, J; Wohn, C | 1 |
2 other study(ies) available for imiquimod and Vascular Diseases
Article | Year |
---|---|
Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice.
Topics: Acetophenones; Animals; Antioxidants; Autoantibodies; Autoimmunity; Blood Pressure; Blood Pressure Determination; Cyclic N-Oxides; Female; Hypertension; Imiquimod; Interleukin-17; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Spin Labels; T-Lymphocytes, Regulatory; Toll-Like Receptor 7; Vascular Diseases | 2020 |
Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis.
Topics: Animals; Antibodies, Blocking; Aorta; Disease Models, Animal; Disease Progression; Humans; Imiquimod; Immunotherapy; Inflammation; Interleukin-17; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Oxidative Stress; Psoriasis; Reactive Oxygen Species; Skin; Vascular Diseases | 2019 |